Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational …

CB Mishra, P Pandey, RD Sharma… - Briefings in …, 2021 - academic.oup.com
The global pandemic crisis, coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed the lives of millions of …

[HTML][HTML] In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19

M Sankar, B Ramachandran, B Pandi… - Frontiers in molecular …, 2021 - frontiersin.org
COVID-19 is one of the members of the coronavirus family that can easily assail humans. As
of now, 10 million people are infected and above two million people have died from COVID …

Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic

Z Fakhar, B Faramarzi, S Pacifico… - Journal of Biomolecular …, 2021 - Taylor & Francis
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …

Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a …

SK Sinha, SK Prasad, MA Islam, SS Gurav… - Journal of …, 2021 - Taylor & Francis
At present, the world is facing a pandemic named as COVID-19, caused by SARS-CoV-2.
Traditional Chinese medicine has recommended the use of liquorice (Glycyrrhiza species) …

[HTML][HTML] Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19

R Patil, R Chikhale, P Khanal, N Gurav… - Informatics in medicine …, 2021 - Elsevier
Bioflavonoids are the largest group of plant-derived polyphenolic compounds with diverse
biological potential and have also been proven efficacious in the treatment of Severe Acute …

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development

P Pandey, JS Rane, A Chatterjee, A Kumar… - Journal of …, 2021 - Taylor & Francis
Spike glycoprotein, a class I fusion protein harboring the surface of SARS-CoV-2 (SARS-
CoV-2S), plays a seminal role in the viral infection starting from recognition of the host cell …

[HTML][HTML] Evaluation of clove phytochemicals as potential antiviral drug candidates targeting SARS-CoV-2 Main protease: computational docking, molecular dynamics …

A Chandra Manivannan, A Malaisamy… - Frontiers in Molecular …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can cause a
sudden respiratory disease spreading with a high mortality rate arising with unknown …

Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches

H Kalhor, S Sadeghi, H Abolhasani… - Journal of …, 2022 - Taylor & Francis
Most recently, the new coronavirus (SARS-CoV-2) has been recognized as a pandemic by
the World Health Organization (WHO) while this virus shares substantial similarity with …

Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics …

F Mosquera-Yuqui, N Lopez-Guerra… - Journal of …, 2022 - Taylor & Francis
Given the highly contagious nature of SARS-CoV-2, it has resulted in an unprecedented
number of COVID-19 infected and dead people worldwide. Since there is currently no …

Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment

SS Swain, SR Singh, A Sahoo… - Journal of Biomolecular …, 2022 - Taylor & Francis
At the health emergence, no such potent prophylactic therapy is available to control the
deadly emerged Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) …